RECRUITING

Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the outcomes of patients with sacroiliac joint pain treated with the CATAMARAN SI Joint Fusion System.

Official Title

Prospective, Multi-Center, Single Arm Post-Market Feasibility Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System

Quick Facts

Study Start:2022-11-14
Study Completion:2026-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05633888

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of sacroiliac joint disruption or degenerative sacroiliitis based on ALL of the following:
  2. * Patient has pain at or close to the posterior superior iliac spine (PSIS) with possible radiation into buttocks, posterior thigh or groin and can point with a single finger to the location of pain (Fortin Finger Test), and
  3. * Patient has at least 3 of 5 physical examination maneuvers specific for SI joint pain (Fabers, Compression, Distraction,Thigh thrust, Gaenslen's test, and/or Sacral thrust test), and
  4. * Patient has improvement in lower back pain VAS of at least 50% of the pre injection VAS after fluoroscopic controlled injection of local anesthetic into affected SI joint(s) (including previous documented test \<6 months ago)
  5. * Patient has failed conservative care (non-surgical) \> 6 months
  6. * Patient has a pre-operative Oswestry Disability Index score \> 30%
  7. * Patient has a pre-operative SI joint pain score of \> 50 on a 0-100 mm visual analog scale (VAS)
  8. * Patient, or authorized representative, signs a written Informed Consent form to participate in the study
  9. * Patient is willing and able to complete study follow-up requirements
  1. * Planned bi-lateral SI joint fixation
  2. * Severe lower back pain due to other causes, such as lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, and lumbar vertebral body fracture (this is done by physical exam, medical history, and MRI/CT/X-ray as required)
  3. * Other known sacroiliac pathology such as: sacral dysplasia, inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA- associated spondyloarthropathy), tumor, acute fracture, crystal arthropathy
  4. * History of recent (\<1 year) fracture of the pelvis with documented malunion, non-union of sacrum or ilium or any type of internal fixation of the pelvic ring
  5. * Severe osteoporosis
  6. * Paget's disease, osteomalacia, osteomalacia or other metabolic bone disease
  7. * Any condition or anatomy that makes treatment with the CATAMARAN SI Joint Fusion System infeasible including deformity
  8. * Known allergy to titanium or titanium alloys
  9. * Morbid obesity
  10. * Active malignancy: a history of any invasive malignancy (except non-melanoma skin cancer), unless the subject has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least five years
  11. * Patient has systemic infection or active infection at the treatment site
  12. * Chronic rheumatologic condition (e.g., rheumatoid arthritis)
  13. * Patient has uncontrolled diabetes
  14. * Patient is currently receiving or seeking worker's compensation, disability remuneration, and/or involved in injury litigation
  15. * Prominent neurologic condition that would interfere with physical therapy
  16. * Patient is pregnant or wishes to become pregnant in the next two years
  17. * Patient is not likely to comply with the follow-up evaluation schedule
  18. * Patient is participating in a clinical trial of another investigational drug or device in which the primary endpoint has not occurred
  19. * Patient has a psychiatric disease (e.g., schizophrenia, major depression, personality disorders) that could interfere with study participation
  20. * Known or suspected drug or alcohol abuse
  21. * Patient is a prisoner or a ward of the state

Contacts and Locations

Study Contact

Calvin Lincé
CONTACT
(510)274-7483
clince@linceconsulting.com

Study Locations (Sites)

Northwest Specialty Hospital
Coeur d'Alene, Idaho, 83815
United States
Comprehensive Pain and Spine Specialists
Muncie, Indiana, 47304
United States
Vitality Pain Centers
Louisville, Kentucky, 40241
United States
Orthopedic Associates of Duluth
Duluth, Minnesota, 55805
United States
St. Louis Pain Consultants
Chesterfield, Missouri, 63017
United States
St. George Orthopedic Spine
Saint George, Utah, 84790
United States

Collaborators and Investigators

Sponsor: Tenon Medical

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-14
Study Completion Date2026-01

Study Record Updates

Study Start Date2022-11-14
Study Completion Date2026-01

Terms related to this study

Additional Relevant MeSH Terms

  • Sacroiliac Joint Disruption
  • Degenerative Sacroiliitis